Correlation Between Deletion of the CDKN2 Gene and Tyrosine Kinase Inhibitor Resistance in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-016-0270-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2011English

Philadelphia Chromosome-Positive De Novo Acute Myeloid Leukemia Treated With Chemotherapy and Second-Generation Tyrosine Kinase Inhibitor

Cureus
2019English

Lymphoblasts Expressing Surface IgM in the Absence of Kappa and Lambda in Philadelphia Positive Acute Lymphoblastic Leukemia: Philadelphia Chromosome Positive Transitional Pre-B Acute Lymphoblastic Leukemia

Clinical Case Reports and Reviews
2018English

A Pathway-Based Gene Signature Correlates With Therapeutic Response in Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Modern Pathology
Forensic MedicinePathology
2010English

Tyrosine Kinase Inhibitors in BCR-ABL Positive Acute Lymphoblastic Leukemia

Haematologica
Hematology
2015English

Current Paradigms in the Management of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in Adults

American Journal of Hematology
Hematology
2017English

Philadelphia Chromosome-Positive Acute Myelocytic Leukemia With French-American-British M2 Morphology, Refractory to Tyrosine Kinase Inhibitors

Tenri Medical Bulletin
2012English

Immunologic Characterization of the Tumor-Specific BCR-Abl Junction in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
1990English

Effective Re-Induction Therapy With Dasatinib and Clofarabine in Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Drugs and Therapy Studies
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy